Video

Dr. Lacouture on Dermatologist Communication

Mario E. Lacouture, MD, dermatologist, Memorial Sloan-Kettering Cancer Center, explains the challenges that need to be overcome to improve communication between oncologists and dermatologists.

Mario E. Lacouture, MD, dermatologist, Memorial Sloan-Kettering Cancer Center, explains the challenges that need to be overcome to improve communication between oncologists and dermatologists.

Lacouture says that one of the major challenges stems from an overall lack of dermatologists. As a result, only 8% of patients who develop a dermatologic side effect will actually see a dermatologist during therapy.

The timing of communication is important as oncologists need to quickly judge whether or not to continue with therapy. At the initial referral to a dermatologist, the oncologist needs to provide information about duration of treatment and type of therapy. This can be used to more accurately determine the cause of the adverse event.

Dermatologists and oncologists have different systems for grading side effects in patients. To provide an accurate classification of adverse events, dermatologists must be aware of the language and terminology used by oncologists.

Related Videos
Lajos Pusztai, MD, DPhil
Hope S. Rugo, MD
Marc Machaalani, MD
Craig Eckfeldt, MD, PhD, assistant professor, medicine, faculty, Microbiology, Immunology, and Cancer Biology PhD Graduate Program, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
Alicia Morgans, MD, MPH, genitourinary medical oncologist, medical director, Survivorship Program, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Alfred L. Garfall, MD, MS
Razane El Hajj Chehade, MD
Mark Juckett, MD, professor, medicine, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
Coral Olazagasti, MD
Barbara Jane O’Brien, MD, associate professor, Neuro-Oncology, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center